This article was originally published in The Tan Sheet
Executive SummaryPOM Wonderful has developed and patented a form of polyphenol antioxidants from pomegranate that is "so concentrated that only a small amount is needed to obtain an optimal level of daily antioxidants," according to the Los Angeles, Calif.-based firm. "For consumers who are not seeking additional calories and sugars, this is an important product benefit." POMx currently is available to consumers as the active ingredient in POM Tea, which launched in May. At this time, POM Wonderful has no plans to offer the compound in non-beverage products, according to a spokesperson. The announcement of the ingredient's availability follows the publication of several recent studies on the health benefits of pomegranates, including a July 1 Clinical Cancer Research study finding that a daily regime of POM Wonderful juice prolonged prostate-specific antigen (PSA) doubling time from 15 to 54 months. The study was supported by a grant from the firm...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.